Data / Form D filings / STABILUX BIOSCIENCES, INC.
STABILUX BIOSCIENCES, INC.: Form D filing
STABILUX BIOSCIENCES, INC., a biotechnology company in Ann Arbor, MI, filed a Form D with the SEC in 2024. The latest, on May 16, 2024, reports $554,381 sold of a $3 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 600 S WAGNER ROAD, Ann Arbor, MI, 48103
- Phone
- (906) 487-2900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Michigan
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2023675
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 16, 2024 | New notice | $3,000,000 | $554,381 | $2,445,619 | 9 | Apr 24, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JONATHAN KHIN LEINONEN | Executive Officer, Director | |
| YOKE KHIN YAP | Executive Officer, Director | |
| MICHAEL KHIN MORTLOCK | Executive Officer | |
| MARK KHIN EHLERT | Director | |
| STEVE KHIN TOKARZ | Executive Officer, Director | |
| JOHN KHIN RANSOM | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of May 13, 2024 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what STABILUX BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.